ClearPoint Neuro, Inc. (CLPT) Operating Margin
- Operating margin · 12 months: Value -73.42%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -73.42% | Operating income / revenue. Period ending 2026-06-30. $-31.04M ÷ $42.28M × 100 ≈ -73.42% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -31.04M USD | Operating Income (Loss) |
| Revenue | 42.28M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 15.84M USD | Research and Development Expense |
| Selling, general and administration | 19.58M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-31.04M | $42.28M | (m) | $15.84M | $19.58M | -73.42% |
| 2026-03-31 | $-26.48M | $40.61M | (m) | $15.04M | $17.41M | -65.20% |
| 2025-12-31 | $-24.16M | $36.97M | (m) | $13.90M | $16.50M | -65.36% |
| 2025-09-30 | $-22.77M | $34.33M | (m) | $13.99M | $14.33M | -66.31% |
| 2025-06-30 | $-22.65M | $33.59M | (m) | $13.86M | $13.88M | -67.42% |
| 2025-03-31 | $-21.69M | $32.24M | (m) | $13.15M | $13.25M | -67.29% |
| 2024-12-31 | $-19.75M | $31.39M | (m) | $12.39M | $12.00M | -62.91% |
| 2024-09-30 | $-18.85M | $30.43M | (m) | $11.71M | $11.49M | -61.94% |
| 2024-06-30 | $-18.57M | $28.07M | (m) | $10.83M | $11.23M | -66.17% |
| 2024-03-31 | $-20.96M | $26.16M | (m) | $11.31M | $11.64M | -80.14% |
| 2023-12-31 | $-22.45M | $23.95M | (m) | $11.71M | $11.76M | -93.70% |
| 2023-09-30 | $-22.21M | $22.32M | (m) | $11.98M | $11.41M | -99.51% |
| 2023-06-30 | $-21.11M | $21.70M | (m) | $12.21M | $10.91M | -97.25% |
| 2023-03-31 | $-18.18M | $20.95M | (m) | $11.02M | $10.39M | -86.77% |
| 2022-12-31 | $-16.33M | $20.55M | (m) | $10.89M | $9.61M | -79.47% |
| 2022-09-30 | $-15.85M | $19.66M | (m) | $10.05M | $11.34M | -80.60% |
| 2022-06-30 | $-15.85M | $19.09M | (m) | $10.13M | $10.85M | -83.06% |
| 2022-03-31 | $-15.06M | $17.30M | (m) | $9.96M | $9.84M | -87.03% |
| 2021-12-31 | $-13.37M | $16.30M | (m) | $8.98M | $8.76M | -82.05% |
| 2021-09-30 | $-11.66M | $15.73M | (m) | $8.16M | $7.59M | -74.09% |
| 2021-06-30 | $-9.12M | $14.68M | (m) | $6.74M | $6.42M | -62.16% |
| 2021-03-31 | $-7.19M | $13.74M | (m) | $5.43M | $5.65M | -52.33% |
| 2020-12-31 | $-6.22M | $12.83M | (m) | $4.69M | $5.27M | -48.48% |
| 2020-09-30 | $-5.37M | $12.32M | (m) | $3.74M | $5.32M | -43.60% |
| 2020-06-30 | $-5.01M | $11.73M | (m) | $3.29M | $4.98M | -42.72% |
| 2020-03-31 | $-4.83M | $11.86M | (m) | $3.17M | $4.65M | -40.72% |
| 2019-12-31 | $-4.59M | $11.22M | (m) | $2.92M | $4.30M | -40.95% |
| 2019-09-30 | $-4.15M | $10.28M | (m) | $2.53M | $4.20M | -40.41% |
| 2019-06-30 | $-4.45M | $9.16M | (m) | $2.38M | $4.25M | -48.57% |
| 2019-03-31 | $-4.79M | $8.20M | (m) | $2.35M | $4.31M | -58.43% |
| 2018-12-31 | $-5.25M | $7.35M | (m) | $2.31M | $4.33M | -71.37% |
| 2018-09-30 | $-6.10M | $6.76M | (m) | $2.41M | $4.38M | -90.31% |
| 2018-06-30 | $-6.22M | $6.67M | (m) | $2.38M | $4.17M | -93.35% |
| 2018-03-31 | $-6.41M | $7.00M | (m) | $2.80M | $4.02M | -91.62% |
| 2017-12-31 | $-6.34M | $7.38M | (m) | $2.81M | $4.05M | -85.86% |
| 2017-09-30 | $-6.29M | $7.34M | (m) | $2.76M | $7.95M | -85.80% |
| 2017-06-30 | $-6.68M | $7.23M | (m) | $2.86M | $8.07M | -92.28% |
| 2017-03-31 | $-6.91M | $6.36M | (m) | $2.53M | $8.04M | -108.58% |
| 2016-12-31 | $-7.49M | $5.75M | (m) | $2.63M | $7.97M | -130.25% |
| 2016-09-30 | $-7.12M | $5.63M | (m) | $2.62M | $7.51M | -126.52% |
| 2016-06-30 | $-7.34M | $5.26M | (m) | $2.41M | $7.76M | -139.57% |
| 2016-03-31 | $-7.96M | $4.98M | (m) | $2.09M | $8.06M | -159.97% |
| 2015-12-31 | $-8.97M | $4.59M | (m) | $1.96M | $8.37M | -195.34% |
| 2015-09-30 | $-10.23M | $4.04M | (m) | $2.14M | $8.86M | -253.14% |
| 2015-06-30 | $-10.92M | $3.43M | (m) | $2.54M | $8.79M | -318.57% |
| 2015-03-31 | $-10.46M | $3.79M | (m) | $3.01M | $8.53M | -275.75% |
| 2014-12-31 | $-5.32M | $3.60M | (m) | $3.30M | $8.04M | -147.61% |
| 2014-09-30 | $-4.71M | $3.82M | (m) | $3.27M | $7.82M | -123.27% |
| 2014-06-30 | $-3.95M | $4.12M | (m) | $3.13M | $7.45M | -96.06% |
| 2014-03-31 | $-3.92M | $3.49M | (m) | $2.97M | $7.23M | -112.23% |
| 2013-12-31 | $-7.47M | $3.93M | (m) | $2.92M | $7.06M | -190.17% |
| 2013-09-30 | $-5.89M | $4.62M | (m) | $2.97M | $6.48M | -127.53% |
| 2013-06-30 | $-5.04M | $4.82M | (m) | $2.82M | $6.22M | -104.61% |
| 2013-03-31 | $-3.34M | $5.34M | (m) | $2.57M | $6.32M | -62.61% |
| 2012-12-31 | $-3.13M | $5.06M | (m) | $2.48M | $6.03M | -61.87% |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $-5.92M | $3.82M | (m) | $4.25M | $4.83M | -155.09% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-9.52M | $2.67M | (m) | $5.68M | $4.70M | -356.45% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |